在慢性疼痛中使用医生对患者导向的加巴丁的比较描述性分析 - - 一份初步报告
Qing Zhao Ruan1, Christopher L Robinson1, Thomas T Simopoulos1
1Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Pain physician
|October 17, 2023
概括
与固定时间表相比,使用加巴丁可变剂量计划的患者报告了更好的疼痛管理效果和满意度. 这项试点研究表明,可变剂量可以改善慢性疼痛的治疗结果.
科学领域:
- 疼痛医学 医学 疼痛医学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- gabapentin 是一种常见的治疗神经病痛的药物,通常使用固定增量剂量策略进行处方.
- 这项研究探讨了自主短期剂量变化的潜在益处,用于治疗慢性疼痛.
研究的目的:
- 调查固定与可变的 gabapentin 剂量表的频率.
- 为了将 gabapentin 使用模式与患者报告的疗效,满意度和副作用相关联.
主要方法:
- 进行了一项横截面观察调查,对最近为慢性疼痛处方加巴丁的患者进行了观察.
- 参与者通过电话询问他们的剂量模式,感知有效性,满意度和副作用,使用5分利克尔特尺度.
- 使用GraphPad Prism进行统计分析.
主要成果:
- 在接受调查的92名仍在服用 gabapentin 的患者中,27%使用了可变剂量计划,而73%使用了固定的计划.
- 可变剂量队列报告了显著更好的疗效 (P=0.027) 和满意度 (P=0.036).
- 固定剂量和可变剂量组之间没有观察到副作用概况的显著差异.
结论:
- 显著的比例的患者自我管理可变的 gabapentin 剂量,这与改善的疗效和满意度有关.
- 可变剂量可以为改善治疗结果提供替代方案,或者对于生活方式与固定疗程不相容的患者来说,可变剂量可以提供替代方案.
- 需要进一步的研究来证实这些发现,并仔细考虑加巴丁的风险和可变方案的剂量参数.
相关概念视频
01:25Analgesia and Pain Management
636
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
646
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
646
01:20Antiepileptic Drugs: Potassium Channel Activators
192
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
192